If you teach a class on stem cells, what book or other resource do you use? I know there are a lot of classes on stem cells going on out there. Part of the challenge of teaching students and trainees about stem cells is that the topic is a moving target. Another challenge is that […]
Teaching a class on stem cells? Here’s the book for you & your students Read More »
Below, guest blogger, John Carbona gives us his account (including pictures) of Day 2 of the Vatican Stem Cell Meeting, which included a talk by Nobel Laureate John Gurdon. Note, you can read John’s post on Day 1 of the meeting including more great pictures here. Friday, April 12, 2012 The Second International Vatican Adult
John Carbona on Day 2 of Vatican Stem Cell Meeting including Gurdon Talk Read More »
CIRM has indicated that the Institute of Medicine (IOM) recommended that CIRM provide funding for training and research on ethics and regulatory issues. In response to this recommendation and with the perspectives of various “CIRM funded researchers and other experts”, CIRM has responded with a new ethics & regulatory recommendation document. I have read it
CIRM Ethics & Regulatory Steps: highly responsive to IOM Read More »
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for
Stem Cell Person of the Year Finalists: time to vote Read More »
Pluristem Therapeutics Inc. is a publicly traded (NASDAQ) biotech Israeli company that is developing stem cell treatments based on the use of expanded placental stem cells called PLX cells. The Pluristem PLX drug is not approved for treating patients at this time in any country, however Pluristem has treated a handful of patients via something
Money and stem cell ‘miracles’: Pluristem questioned on ethics Read More »
What are Conflict of Interests (COI)? The term COI is sometimes used inappropriately as a weapon by one party to attempt to discredit others. We see this more and more frequently in the stem cell field with boosters of for-profit, non-FDA vetted adult stem cell clinics attacking scientists for supposed COIs for what…..apparently for simply
Real and imaginary conflicts of interest: a helpful guide Read More »
Why is the Texas stem cell company Celltex so super duper private about itself? I’m not sure. It has been the subject of much discussion in the stem cell field in the past year. Unfortunately, much of the news has been negative, largely related to their former head of ethics, Glenn McGee, who also was
Wondering why Celltex is still so silent Read More »
What are the top 10 stem cell events of a crazy 2012 to date? Based on this wild list in just over 3 months, I would say 2012 overall will prove to be a memorable one. 1. Celltex and McGee versus University of Minnesota’s Turner and Elliott. Glenn McGee, at one point both editor of American
Stem cell stories of a crazy 2012 so far including Celltex Read More »
Recently, there has been a brewing controversy surrounding a journal called American Journal of Bioethics (AJOB), a company called CellTex, a bioethicist named Dr. Glenn McGee who founded and used to run AJOB until he recently resigned, and two University of Minnesota professors, Drs. Carl Elliott and Leigh Turner who have been publicly critical of
Celltex versus University of Minnesota: support for Elliott and Turner Read More »
Lately I have been critical of an ultra-conservative political think tank-like foundation called the Witherspoon Institute. They have recently joined the federal lawsuit as friends of the plaintiffs suing to stop federal funding of embryonic stem cell research. The Witherspoon Council has just published a 100+ page report on stem cells in the very conservative, somewhat obscure
A critique of the Witherspoon Institute stem cell report Read More »